Background Glioblastoma multiforme (GBM) is the most common and malignant primary
brain tumour in adults. Due to the ageing of the population, diagnosis in the elderly is …

Introduction Treating high grade gliomas in the elderly is a challenge for multidisciplinary
teams. Most studies on this topic exclude patients aged> 65 and a Karnofsky Performance …

Background As the population ages, the proportion of elderly patients with glioblastomas
has increased. Recently, many researchers have focused on the treatments available to and …

Background: Glioblastoma (GBM) is commonly diagnosed in patients older than 60 years,
but the treatment protocols are mostly based on trials in patients aged up to 70 years. These …

The appropriate treatment approach for elderly patients with glioblastoma multiforme (GBM)
is unclear, although different studies suggest survival benefit in fit patients treated with …

Glioblastoma is the most common primary brain tumor. Recent evidence suggests that
aggressive treatment is also effective in elderly patients. However, large patient series are …

Objective To evaluate the effects of combined treatments on the outcome and survival of
elderly (≥ 65 years) patients with glioblastoma as compared with younger ones. Material …

Objective: Prognostic factors are poorly defined for the elderly subpopulation with
glioblastoma multiforme and have been exclusively related to conventional survival …

Objective Although glioblastoma multiforme is more common in patients older than 65 years,
the elderly population is often excluded from clinical studies. Decision making in this …

Object The objective of this study was to analyze whether age influences the outcome of
patients with glioblastoma and whether elderly patients with glioblastoma can tolerate the …